BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu YJ, Wang P, Wang X, Peng J, Zhu YW, Shen N. The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis. Oncotarget. 2016;7:37361-37369. [PMID: 27008698 DOI: 10.18632/oncotarget.8156] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Liou M, Hsu H, Leong K, Chen Y, Wang Y, Hung W, Lee H, Tsai H, Tseng C. Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer. Thyroid 2018;28:1479-89. [DOI: 10.1089/thy.2017.0639] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
2 Wu ZX, Liu Z, Jiang HL, Pan HM, Han WD. Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer. Oncotarget 2016;7:67586-96. [PMID: 27588489 DOI: 10.18632/oncotarget.11707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
3 Billingsley MM, Riley RS, Day ES. Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods. PLoS One 2017;12:e0177592. [PMID: 28494030 DOI: 10.1371/journal.pone.0177592] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
4 Liu X, Ran R, Shao B, Rugo HS, Yang Y, Hu Z, Wei Z, Wan F, Kong W, Song G, Jiang H, Liang X, Zhang R, Yan Y, Xu G, Li H. Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer. Chin J Cancer Res 2018;30:315-26. [PMID: 30046226 DOI: 10.21147/j.issn.1000-9604.2018.03.04] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Tan G, Chu C, Gui X, Li J, Chen Q. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis. Medicine (Baltimore) 2018;97:e0197. [PMID: 29595655 DOI: 10.1097/MD.0000000000010197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
6 Vishnoi M, Liu NH, Yin W, Boral D, Scamardo A, Hong D, Marchetti D. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling. Mol Oncol 2019;13:1913-26. [PMID: 31216110 DOI: 10.1002/1878-0261.12533] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
7 Mansouri S, Mokhtari-Hesari P, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L. The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review. Curr Stem Cell Res Ther 2019;14:519-29. [PMID: 30843493 DOI: 10.2174/1574888X14666190306103759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wang S, Du H, Li G. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis. Oncotarget 2017;8:15815-26. [PMID: 28178659 DOI: 10.18632/oncotarget.15012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Hwang WL, Hwang KL, Miyamoto DT. The promise of circulating tumor cells for precision cancer therapy. Biomark Med 2016;10:1269-85. [PMID: 27924634 DOI: 10.2217/bmm-2016-0192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Sabatier R, Pierga JY, Curé H, Abulnaja R, Lambaudie E, Bidard FC, Extra JM, Sfumato P, Gonçalves A. Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial. Cancers (Basel) 2021;13:E140. [PMID: 33466225 DOI: 10.3390/cancers13010140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lu YJ, Wang P, Peng J, Wang X, Zhu YW, Shen N. Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer. Sci Rep 2017;7:905. [PMID: 28424486 DOI: 10.1038/s41598-017-01066-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 Chistiakov DA, Chekhonin VP. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme. Experimental and Molecular Pathology 2018;105:166-74. [DOI: 10.1016/j.yexmp.2018.07.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
13 Choi MK, Kim GH, I H, Park SJ, Lee MW, Lee BE, Park DY, Cho YK. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2019;34:552-60. [PMID: 30426559 DOI: 10.1111/jgh.14543] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
14 Xu HT, Miao J, Liu JW, Zhang LG, Zhang QG. Prognostic value of circulating tumor cells in esophageal cancer. World J Gastroenterol 2017;23:1310-8. [PMID: 28275311 DOI: 10.3748/wjg.v23.i7.1310] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li Y, Wu G, Yang W, Wang X, Duan L, Niu L, Zhang Y, Liu J, Hong L, Fan D. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis. BMC Cancer 2020;20:581. [PMID: 32571299 DOI: 10.1186/s12885-020-07059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Chen MT, Sun HF, Zhao Y, Fu WY, Yang LP, Gao SP, Li LD, Jiang HL, Jin W. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep. 2017;7:9254. [PMID: 28835702 DOI: 10.1038/s41598-017-10166-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
17 Shen N, Lu Y, Wang X, Peng J, Zhu Y, Cheng L. Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis. Oncotarget 2017;8:50864-72. [PMID: 28881610 DOI: 10.18632/oncotarget.15140] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
18 Weiner-Gorzel K, Murphy M. Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188518. [PMID: 33545296 DOI: 10.1016/j.bbcan.2021.188518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. The biology and clinical potential of circulating tumor cells. Radiol Oncol 2019;53:131-47. [PMID: 31104002 DOI: 10.2478/raon-2019-0024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
20 Wickramaratne B, Pappas D. Tandem microfluidic chip isolation of prostate and breast cancer cells from simulated liquid biopsies using CD71 as an affinity ligand. RSC Adv 2020;10:32628-37. [DOI: 10.1039/d0ra03626a] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Abreu M, Cabezas-Sainz P, Pereira-Veiga T, Falo C, Abalo A, Morilla I, Curiel T, Cueva J, Rodríguez C, Varela-Pose V, Lago-Lestón R, Mondelo P, Palacios P, Moreno-Bueno G, Cano A, García-Caballero T, Pujana MÁ, Sánchez-Piñón L, Costa C, López R, Muinelo-Romay L. Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells. J Clin Med 2020;9:E353. [PMID: 32012729 DOI: 10.3390/jcm9020353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Zhou S, Wang L, Zhang W, Liu F, Zhang Y, Jiang B, Wang J, Yuan H. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma. Technol Cancer Res Treat 2021;20:1533033821990037. [PMID: 33641530 DOI: 10.1177/1533033821990037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Riethdorf S, O'flaherty L, Hille C, Pantel K. Clinical applications of the CellSearch platform in cancer patients. Advanced Drug Delivery Reviews 2018;125:102-21. [DOI: 10.1016/j.addr.2018.01.011] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 30.3] [Reference Citation Analysis]